BOXER CAPITAL, LLC Holdings

BOXER CAPITAL, LLC is an investment fund managing more than 1.78B US dollars. The largest holdings include Mirati Therapeutics, Cytokinetics, Incorporated and Prometheus Biosciences. In Q3 2022 the fund bought assets of total value of 177.21M US dollars and sold assets of total value of 102.85M US dollars.

$1.77B

portfolio value

+14.16%

quarter

-38.12%

1 year

+4.94%

3 years

+33.72%

5 years

BOXER CAPITAL, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	44510000	53357000
Q2 2016	34585000	13398000
Q3 2016	81347000	13099000
Q4 2016	70796000	35088000
Q1 2017	143262000	4763000
Q2 2017	70746000	78833000
Q3 2017	37047000	67077000
Q4 2017	198465000	89433000
Q1 2018	346629000	26994000
Q2 2018	250674000	172037000
Q3 2018	134118000	140329000
Q4 2018	90467000	112732000
Q1 2019	262034000	221612000
Q2 2019	329096000	67628000
Q3 2019	379043000	5784000
Q4 2019	435951000	177071000
Q1 2020	224987000	126185000
Q2 2020	278574000	87400000
Q3 2020	580381000	54012000
Q4 2020	450794000	281911000
Q1 2021	300004000	188092000
Q2 2021	196082000	47896000
Q3 2021	442996000	269010000
Q4 2021	356405000	633641000
Q1 2022	266833000	297994000
Q2 2022	64570000	105622000
Q3 2022	177212000	102854000

BOXER CAPITAL, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 7.86% Portfolio value: 139.68M Avg. open price: $60.76 Current price: $92.75 P/L: +52.65% Bought +13.28% shares Q1 2021	share	7.86%	139.68M	$60.76	$92.75	+52.65%	Bought +13.28% shares Q1 2021
Biotechnology Cytokinetics, Incorporated Portfolio share: 5.72% Portfolio value: 101.74M Avg. open price: N/A Current price: $38.12 P/L: N/A N/A Q4 2020	share	5.72%	101.74M	N/A	$38.12	N/A	N/A Q4 2020
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 5.69% Portfolio value: 101.14M Avg. open price: N/A Current price: $37.72 P/L: N/A N/A Q1 2022	share	5.69%	101.14M	N/A	$37.72	N/A	N/A Q1 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 5.49% Portfolio value: 97.61M Avg. open price: $24.62 Current price: $24.25 P/L: -1.50% Bought +64.82% shares Q3 2022	share	5.49%	97.61M	$24.62	$24.25	-1.50%	Bought +64.82% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 5.01% Portfolio value: 89.04M Avg. open price: $24.09 Current price: $49.41 P/L: +105.09% N/A Q1 2022	share	5.01%	89.04M	$24.09	$49.41	+105.09%	N/A Q1 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 4.42% Portfolio value: 78.57M Avg. open price: $27.05 Current price: $24.32 P/L: -10.08% Bought +14.35% shares Q3 2022	share	4.42%	78.57M	$27.05	$24.32	-10.08%	Bought +14.35% shares Q3 2022
Biotechnology BeiGene, Ltd. Portfolio share: 3.79% Portfolio value: 67.41M Avg. open price: $107.04 Current price: $188.71 P/L: +76.29% Sold -34.57% shares Q4 2021	share	3.79%	67.41M	$107.04	$188.71	+76.29%	Sold -34.57% shares Q4 2021
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 3.30% Portfolio value: 58.66M Avg. open price: N/A Current price: $38.55 P/L: N/A Sold -5.27% shares Q3 2022	share	3.30%	58.66M	N/A	$38.55	N/A	Sold -5.27% shares Q3 2022
Biotechnology Tyra Biosciences, Inc. Portfolio share: 3.19% Portfolio value: 56.68M Avg. open price: $17.59 Current price: $6.89 P/L: -60.83% Bought +1.98% shares Q4 2021	share	3.19%	56.68M	$17.59	$6.89	-60.83%	Bought +1.98% shares Q4 2021
Biotechnology Relay Therapeutics, Inc. Portfolio share: 2.73% Portfolio value: 48.52M Avg. open price: $31.86 Current price: $18.36 P/L: -42.37% Sold -18.73% shares Q3 2022	share	2.73%	48.52M	$31.86	$18.36	-42.37%	Sold -18.73% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 2.41% Portfolio value: 42.84M Avg. open price: $72.19 Current price: $43.52 P/L: -39.71% Sold -28.61% shares Q2 2020	share	2.41%	42.84M	$72.19	$43.52	-39.71%	Sold -28.61% shares Q2 2020
Biotechnology Gossamer Bio, Inc. Portfolio share: 2.41% Portfolio value: 42.79M Avg. open price: $10.8 Current price: $9.29 P/L: -13.95% Bought +45.06% shares Q3 2022	share	2.41%	42.79M	$10.8	$9.29	-13.95%	Bought +45.06% shares Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 2.31% Portfolio value: 41.03M Avg. open price: N/A Current price: $20.04 P/L: N/A Sold -32.52% shares Q2 2022	share	2.31%	41.03M	N/A	$20.04	N/A	Sold -32.52% shares Q2 2022
Biotechnology Merus N.V. Portfolio share: 2.14% Portfolio value: 38.05M Avg. open price: $17.53 Current price: $14.2 P/L: -19.00% Bought +33.07% shares Q1 2021	share	2.14%	38.05M	$17.53	$14.2	-19.00%	Bought +33.07% shares Q1 2021
Biotechnology PMV Pharmaceuticals, Inc. Portfolio share: 2.12% Portfolio value: 37.64M Avg. open price: $26.42 Current price: $9.89 P/L: -62.57% Sold -9.57% shares Q3 2022	share	2.12%	37.64M	$26.42	$9.89	-62.57%	Sold -9.57% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 2.11% Portfolio value: 37.46M Avg. open price: $9.61 Current price: $33.96 P/L: +253.48% Sold -31.31% shares Q4 2021	share	2.11%	37.46M	$9.61	$33.96	+253.48%	Sold -31.31% shares Q4 2021
Biotechnology BELLUS Health Inc. Portfolio share: 1.90% Portfolio value: 33.79M Avg. open price: $9.63 Current price: $10.02 P/L: +4.00% Bought +7.56% shares Q4 2021	share	1.90%	33.79M	$9.63	$10.02	+4.00%	Bought +7.56% shares Q4 2021
Biotechnology AnaptysBio, Inc. Portfolio share: 1.87% Portfolio value: 33.16M Avg. open price: N/A Current price: $28.65 P/L: N/A N/A Q4 2019	share	1.87%	33.16M	N/A	$28.65	N/A	N/A Q4 2019
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 1.85% Portfolio value: 32.86M Avg. open price: $4.12 Current price: $17.77 P/L: +331.31% Bought +188.23% shares Q2 2020	share	1.85%	32.86M	$4.12	$17.77	+331.31%	Bought +188.23% shares Q2 2020
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 1.75% Portfolio value: 31.13M Avg. open price: $34.97 Current price: $39.62 P/L: +13.30% N/A Q1 2022	share	1.75%	31.13M	$34.97	$39.62	+13.30%	N/A Q1 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.67% Portfolio value: 29.67M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q3 2022	share	1.67%	29.67M	N/A	$28.09	N/A	N/A Q3 2022
Biotechnology Veru Inc. Portfolio share: 1.62% Portfolio value: 28.8M Avg. open price: N/A Current price: $5.82 P/L: N/A N/A Q3 2022	share	1.62%	28.8M	N/A	$5.82	N/A	N/A Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 1.59% Portfolio value: 28.31M Avg. open price: $23.93 Current price: $44.04 P/L: +84.03% Bought +99.64% shares Q3 2020	share	1.59%	28.31M	$23.93	$44.04	+84.03%	Bought +99.64% shares Q3 2020
Biotechnology Tango Therapeutics, Inc. Portfolio share: 1.40% Portfolio value: 24.87M Avg. open price: N/A Current price: $7.69 P/L: N/A N/A Q3 2021	share	1.40%	24.87M	N/A	$7.69	N/A	N/A Q3 2021
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 1.37% Portfolio value: 24.27M Avg. open price: N/A Current price: $12.37 P/L: N/A N/A Q2 2019	share	1.37%	24.27M	N/A	$12.37	N/A	N/A Q2 2019
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 1.34% Portfolio value: 23.83M Avg. open price: N/A Current price: $21.45 P/L: N/A N/A Q2 2021	share	1.34%	23.83M	N/A	$21.45	N/A	N/A Q2 2021
Biotechnology Nuvalent, Inc. Portfolio share: 1.32% Portfolio value: 23.52M Avg. open price: N/A Current price: $34.16 P/L: N/A N/A Q3 2021	share	1.32%	23.52M	N/A	$34.16	N/A	N/A Q3 2021
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 1.32% Portfolio value: 23.39M Avg. open price: N/A Current price: $19.03 P/L: N/A Sold -25.43% shares Q1 2019	share	1.32%	23.39M	N/A	$19.03	N/A	Sold -25.43% shares Q1 2019
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 1.24% Portfolio value: 22.10M Avg. open price: N/A Current price: $122.96 P/L: N/A N/A Q2 2022	share	1.24%	22.10M	N/A	$122.96	N/A	N/A Q2 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 1.22% Portfolio value: 21.66M Avg. open price: N/A Current price: $38.83 P/L: N/A Sold -29.99% shares Q4 2021	share	1.22%	21.66M	N/A	$38.83	N/A	Sold -29.99% shares Q4 2021
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 1.16% Portfolio value: 20.67M Avg. open price: $23.54 Current price: $15.24 P/L: -35.26% Bought +583.21% shares Q1 2022	share	1.16%	20.67M	$23.54	$15.24	-35.26%	Bought +583.21% shares Q1 2022
Biotechnology Exelixis, Inc. Portfolio share: 1.10% Portfolio value: 19.6M Avg. open price: N/A Current price: $17.22 P/L: N/A N/A Q3 2022	share	1.10%	19.6M	N/A	$17.22	N/A	N/A Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 1.09% Portfolio value: 19.32M Avg. open price: N/A Current price: $6.72 P/L: N/A N/A Q3 2021	share	1.09%	19.32M	N/A	$6.72	N/A	N/A Q3 2021
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 1.04% Portfolio value: 18.53M Avg. open price: $19.42 Current price: $8.03 P/L: -58.65% Bought +75.92% shares Q1 2022	share	1.04%	18.53M	$19.42	$8.03	-58.65%	Bought +75.92% shares Q1 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 1.03% Portfolio value: 18.31M Avg. open price: N/A Current price: $11.18 P/L: N/A N/A Q2 2020	share	1.03%	18.31M	N/A	$11.18	N/A	N/A Q2 2020
Biotechnology Kinnate Biopharma Inc. Portfolio share: 1.02% Portfolio value: 18.19M Avg. open price: $23.31 Current price: $7.05 P/L: -69.75% Sold -17.59% shares Q3 2022	share	1.02%	18.19M	$23.31	$7.05	-69.75%	Sold -17.59% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 1.02% Portfolio value: 18.18M Avg. open price: N/A Current price: $60.39 P/L: N/A N/A Q3 2021	share	1.02%	18.18M	N/A	$60.39	N/A	N/A Q3 2021
Biotechnology Blueprint Medicines Corporation Portfolio share: 1.02% Portfolio value: 18.12M Avg. open price: $38.23 Current price: $50.19 P/L: +31.27% Sold -45.80% shares Q3 2022	share	1.02%	18.12M	$38.23	$50.19	+31.27%	Sold -45.80% shares Q3 2022
Biotechnology Nurix Therapeutics, Inc. Portfolio share: 0.90% Portfolio value: 15.96M Avg. open price: N/A Current price: $12.38 P/L: N/A Sold -9.56% shares Q4 2020	share	0.90%	15.96M	N/A	$12.38	N/A	Sold -9.56% shares Q4 2020
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.77% Portfolio value: 13.77M Avg. open price: N/A Current price: $11.61 P/L: N/A N/A Q1 2021	share	0.77%	13.77M	N/A	$11.61	N/A	N/A Q1 2021
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 0.61% Portfolio value: 10.82M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	0.61%	10.82M	N/A	$22	N/A	N/A Q3 2022
Biotechnology 89bio, Inc. Portfolio share: 0.46% Portfolio value: 8.10M Avg. open price: N/A Current price: $8.34 P/L: N/A N/A Q2 2022	share	0.46%	8.10M	N/A	$8.34	N/A	N/A Q2 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.44% Portfolio value: 7.84M Avg. open price: N/A Current price: $20.4 P/L: N/A Sold -30.00% shares Q3 2022	share	0.44%	7.84M	N/A	$20.4	N/A	Sold -30.00% shares Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.41% Portfolio value: 7.22M Avg. open price: N/A Current price: $119.41 P/L: N/A N/A Q2 2022	share	0.41%	7.22M	N/A	$119.41	N/A	N/A Q2 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 0.38% Portfolio value: 6.69M Avg. open price: N/A Current price: $15.36 P/L: N/A N/A Q1 2022	share	0.38%	6.69M	N/A	$15.36	N/A	N/A Q1 2022
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 0.37% Portfolio value: 6.54M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q2 2021	share	0.37%	6.54M	N/A	$5.6	N/A	N/A Q2 2021
Biotechnology Milestone Pharmaceuticals Inc. Portfolio share: 0.36% Portfolio value: 6.42M Avg. open price: $5.65 Current price: $4.75 P/L: -15.99% Sold -68.78% shares Q3 2022	share	0.36%	6.42M	$5.65	$4.75	-15.99%	Sold -68.78% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.36% Portfolio value: 6.38M Avg. open price: N/A Current price: $11.09 P/L: N/A N/A Q3 2022	share	0.36%	6.38M	N/A	$11.09	N/A	N/A Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 0.36% Portfolio value: 6.34M Avg. open price: N/A Current price: $12.5 P/L: N/A N/A Q2 2022	share	0.36%	6.34M	N/A	$12.5	N/A	N/A Q2 2022
Biotechnology Rain Therapeutics Inc. Portfolio share: 0.32% Portfolio value: 5.73M Avg. open price: N/A Current price: $6.83 P/L: N/A N/A Q2 2021	share	0.32%	5.73M	N/A	$6.83	N/A	N/A Q2 2021
Biotechnology Selecta Biosciences, Inc. Portfolio share: 0.30% Portfolio value: 5.38M Avg. open price: N/A Current price: $1.31 P/L: N/A N/A Q4 2019	share	0.30%	5.38M	N/A	$1.31	N/A	N/A Q4 2019
Biotechnology BioAtla, Inc. Portfolio share: 0.30% Portfolio value: 5.28M Avg. open price: N/A Current price: $10.52 P/L: N/A N/A Q4 2020	share	0.30%	5.28M	N/A	$10.52	N/A	N/A Q4 2020
Biotechnology Theseus Pharmaceuticals, Inc. Portfolio share: 0.29% Portfolio value: 5.17M Avg. open price: N/A Current price: $6.03 P/L: N/A N/A Q4 2021	share	0.29%	5.17M	N/A	$6.03	N/A	N/A Q4 2021
Biotechnology Centessa Pharmaceuticals plc Portfolio share: 0.28% Portfolio value: 5.03M Avg. open price: N/A Current price: $3.93 P/L: N/A Sold -6.23% shares Q4 2021	share	0.28%	5.03M	N/A	$3.93	N/A	Sold -6.23% shares Q4 2021
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.28% Portfolio value: 5.01M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.28%	5.01M	N/A	$10.04	N/A	N/A Q4 2020
Biotechnology EQRx, Inc. Portfolio share: 0.28% Portfolio value: 4.95M Avg. open price: N/A Current price: $3.46 P/L: N/A N/A Q4 2021	share	0.28%	4.95M	N/A	$3.46	N/A	N/A Q4 2021
Shell Companies Panacea Acquisition Corp. II Portfolio share: 0.28% Portfolio value: 4.9M Avg. open price: N/A Current price: $9.93 P/L: N/A N/A Q2 2021	share	0.28%	4.9M	N/A	$9.93	N/A	N/A Q2 2021
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.22% Portfolio value: 3.96M Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q3 2020	share	0.22%	3.96M	N/A	$9.96	N/A	N/A Q3 2020
Biotechnology DBV Technologies S.A. Portfolio share: 0.21% Portfolio value: 3.77M Avg. open price: $15.23 Current price: $1.31 P/L: -91.40% Sold -71.67% shares Q4 2021	share	0.21%	3.77M	$15.23	$1.31	-91.40%	Sold -71.67% shares Q4 2021
Biotechnology Atreca, Inc. Portfolio share: 0.19% Portfolio value: 3.45M Avg. open price: $21.28 Current price: $1 P/L: -95.32% Bought +27.04% shares Q3 2020	share	0.19%	3.45M	$21.28	$1	-95.32%	Bought +27.04% shares Q3 2020
Biotechnology Black Diamond Therapeutics, Inc. Portfolio share: 0.19% Portfolio value: 3.40M Avg. open price: N/A Current price: $1.86 P/L: N/A N/A Q1 2020	share	0.19%	3.40M	N/A	$1.86	N/A	N/A Q1 2020
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 0.19% Portfolio value: 3.37M Avg. open price: $15.59 Current price: $4.02 P/L: -74.21% Bought +427.00% shares Q1 2022	share	0.19%	3.37M	$15.59	$4.02	-74.21%	Bought +427.00% shares Q1 2022
Biotechnology Alaunos Therapeutics, Inc. Portfolio share: 0.15% Portfolio value: 2.58M Avg. open price: N/A Current price: $0.67 P/L: N/A N/A Q3 2022	share	0.15%	2.58M	N/A	$0.67	N/A	N/A Q3 2022
Biotechnology Gemini Therapeutics, Inc. Portfolio share: 0.12% Portfolio value: 2.13M Avg. open price: N/A Current price: $1.7 P/L: N/A N/A Q1 2021	share	0.12%	2.13M	N/A	$1.7	N/A	N/A Q1 2021
Shell Companies Omega Alpha SPAC Portfolio share: 0.11% Portfolio value: 1.98M Avg. open price: N/A Current price: $10.06 P/L: N/A N/A Q1 2021	share	0.11%	1.98M	N/A	$10.06	N/A	N/A Q1 2021
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.11% Portfolio value: 1.93M Avg. open price: $1.96 Current price: $0.83 P/L: -57.56% N/A Q2 2022	share	0.11%	1.93M	$1.96	$0.83	-57.56%	N/A Q2 2022
Biotechnology MEI Pharma, Inc. Portfolio share: 0.06% Portfolio value: 1.12M Avg. open price: N/A Current price: $0.39 P/L: N/A N/A Q2 2018	share	0.06%	1.12M	N/A	$0.39	N/A	N/A Q2 2018
Biotechnology Protara Therapeutics, Inc. Portfolio share: 0.03% Portfolio value: 619K Avg. open price: $23 Current price: $3.63 P/L: -84.22% N/A Q3 2020	share	0.03%	619K	$23	$3.63	-84.22%	N/A Q3 2020
Biotechnology Codiak BioSciences, Inc. Portfolio share: 0.02% Portfolio value: 382K Avg. open price: $32.3 Current price: $0.67 P/L: -97.93% Sold -42.57% shares Q3 2022	share	0.02%	382K	$32.3	$0.67	-97.93%	Sold -42.57% shares Q3 2022
Biotechnology Cabaletta Bio, Inc. Portfolio share: 0.02% Portfolio value: 351K Avg. open price: $10.84 Current price: $4.97 P/L: -54.15% Sold -66.32% shares Q4 2021	share	0.02%	351K	$10.84	$4.97	-54.15%	Sold -66.32% shares Q4 2021
Biotechnology Bellicum Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 68K Avg. open price: N/A Current price: $0.99 P/L: N/A N/A Q1 2022	share	0.00%	68K	N/A	$0.99	N/A	N/A Q1 2022
NUVATION BIO INC Portfolio share: 0.00% Portfolio value: 45K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.00%	45K	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Surrozen, Inc. Portfolio share: 0.00% Portfolio value: 11K Avg. open price: N/A Current price: $0.05 P/L: N/A N/A Q1 2022	share	0.00%	11K	N/A	$0.05	N/A	N/A Q1 2022
Biotechnology ESSA Pharma Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8 Current price: $3.47 P/L: -56.63% Sold -100.00% shares Q3 2022	share	0.00%	0	$8	$3.47	-56.63%	Sold -100.00% shares Q3 2022
Biotechnology Biomea Fusion, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.77 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.77	N/A	Sold -100.00% shares Q3 2022
Biotechnology GH Research PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.4 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.4	N/A	Sold -100.00% shares Q3 2022
Biotechnology Solid Biosciences Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.26 Current price: $6.46 P/L: -10.99% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.26	$6.46	-10.99%	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $82.88 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$82.88	N/A	Sold -100.00% shares Q3 2022
Biotechnology Nuvation Bio Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.94 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.94	N/A	Sold -100.00% shares Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $26.85 Current price: $76.01 P/L: +183.09% Sold -100.00% shares Q3 2022	share	0.00%	0	$26.85	$76.01	+183.09%	Sold -100.00% shares Q3 2022
Biotechnology Aligos Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.97 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.97	N/A	Sold -100.00% shares Q3 2022
Biotechnology Elevation Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.95 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.95	N/A	Sold -100.00% shares Q3 2022

Showing TOP 82 BOXER CAPITAL's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of BOXER CAPITAL, LLC?

The biggest position of the BOXER CAPITAL, LLC is Mirati Therapeutics, Inc. (MRTX) with 7.86% portfolio share worth of 139.68M US dollars.

Top 5 BOXER CAPITAL's holdings represent 29.76% of the portfolio:

Mirati Therapeutics, Inc. (MRTX) – 7.86%
Cytokinetics, Incorporated (CYTK) – 5.72%
Prometheus Biosciences, Inc. (RXDX) – 5.69%
SpringWorks Therapeutics, Inc. (SWTX) – 5.49%
Apellis Pharmaceuticals, Inc. (APLS) – 5.01%

Who is the portfolio manager of BOXER CAPITAL, LLC?

The portfolio manager of the BOXER CAPITAL, LLC is .

What is the total asset value of the BOXER CAPITAL, LLC portfolio?

BOXER CAPITAL, LLC total asset value (portfolio value) is 1.78B US dollars.

Who is ?

is the portfolio manager of the BOXER CAPITAL, LLC.

What is (BOXER CAPITAL, LLC) fund performance?

BOXER CAPITAL's quarterly performance is +14.16%, annualy -38.12%. In the past 3 years, the value of 's portfolio has increased by +5%. In the past 5 years, the value of the portfolio has increased by +34%.

What is the BOXER CAPITAL, LLC CIK?

BOXER CAPITAL's Central Index Key is 0001465837 .

BOXER CAPITAL, LLC Holdings

BOXER CAPITAL, LLC portfolio value:

BOXER CAPITAL, LLC quarter portfolio value change:

BOXER CAPITAL, LLC 1 year portfolio value change:

BOXER CAPITAL, LLC 3 years portfolio value change:

BOXER CAPITAL, LLC 5 years portfolio value change: